Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
企業コードRDY
会社名Dr Reddy's Laboratories Ltd
上場日Jan 01, 1986
最高経営責任者「CEO」Aghanian (Patrick)
従業員数27811
証券種類Depository Receipt
決算期末Jan 01
本社所在地8-2-337, Road No.3 Banjara Hills
都市HYDERABAD
証券取引所NASDAQ OMX NASDAQ Basic NYSE
国India
郵便番号500-034
電話番号914049002900
ウェブサイトhttps://www.drreddys.com/
企業コードRDY
上場日Jan 01, 1986
最高経営責任者「CEO」Aghanian (Patrick)